Table 1 Characteristics of patients who received lymphadenectomy for lymph node recurrence
|  | Esophagectomy (n = 11) | ER (n = 5) | CRT/CT (n = 4) | Total (n = 20) |
|---|---|---|---|---|
Age, median (range) | 64 (56–84) | 73(65–81) | 65(56–73) | 67(56–84) |
Sex (%) | Â | Â | Â | Â |
 Male | 10 (90.9) | 4 (80.0) | 3 (75.0) | 17 (85.0) |
 Female | 1(9.1) | 1 (20.0) | 1 (25.0) | 3 (15.0) |
Location, Ce/Ut/Mt/Lt | Â | Â | Â | Â |
 Ce | 0 (0) | 0 (0) | 1 (25.0) | 1 (5.0) |
 Ut | 0 (0) | 1 (20.0) | 0 (0) | 1 (5.0) |
 Mt | 9 (81.8) | 3 (60.0) | 2(50.0) | 14 (70.0) |
 Lt | 2 (18.2) | 1 (20.0) | 1 (25.0) | 4 (20.0) |
Stage (%) | Â | Â | Â | Â |
 I | 2 (18.2) | 5 (100) | 0 (0) | 7 (35.0) |
 II | 2 (18.2) | 0 (0) | 1 (25.0) | 3 (15.0) |
 III | 4 (36.4) | 0 (0) | 0 (0) | 4 (20.0) |
 IVA | 2 (18.2) | 0 (0) | 1 (25.0) | 3 (15.0) |
 IVB | 1 (9.1) | 0 (0) | 2 (50.0) | 3 (15.0) |
Initial lymphadenectomy range | Â | Â | Â | Â |
 Three-field | 9 (81.8) | NA | NA | NA |
 The others | 2 (18.2) | NA | NA | NA |
 pR0 | 10 (90.9) | 5 (100) | NA | NA |
 Adjuvant therapy | 4 (36.4) | 0(0) | NA | NA |
RFS, month, median (range) | 13.4 (3.3–68.4) | 50.5 (12.1–61.8) | 19.9 (6.5–28.7) | 15.9 (3.3–68.4) |
Site of recurrence | Â | Â | Â | Â |
 Cervical | 9 (81.8) | 3 (60.0) | 1 (25.0) | 13 (65.0) |
 Mediastinal | 1 (9.1) | 2 (40.0) | 2 (50.0) | 5 (25.0) |
 Abdominal | 1 (9.1) | 0 (0) | 1 (25.0) | 2 (10.0) |
Approach of lymphadenectomy for recurrence | Â | Â | Â | Â |
 Open | 11 | 4 | 3 | 18 |
 Mediastinoscopic | 0 | 1 | 1 | 2 |